1Parisier SC, Agreti CJ,Schwartz GK, et al. Alteration in chol esteatoma fibrohlasts: induction of neoplastic-like phenotype [J] . AmJ Otol, 1993,14:126.
2Bujia J,Sehilling V, Holly A, et al. Hyperproliferation-assoeiated keratin expression in human middle ear choleseatoma [J ]. Aeta Otolaryngol, 1993,113 : 364.
3Ergun S, Zheng X, Carsoo B. Antigen expression of epithelial makers,collagen IV and Ki67 in middle ear cholesteatoma[J] . Acta Otolaryngol, 1994,114 : 295.
4Kuczkowski J, Pawelczyk T, Bakowska A. et al. Expression patterns of Ki67 and telomerase activity in middle ear chol esteatoma[J] . Otol Neurotol, 2007,28 : 204.
5Bujia J,Holly A ,Schilling V,et al. Aberrant exprssion of epi dermal growth factor receptor in aural cholesteatoma[J] . Laryngoscope, 1993,103 : 326.
8Albino AP , Reed JA, Bogdany JK, et al. expression of p53 protein in human middle ear cholesteatomas:pathpgenetic im pieations[J] . Am J Otol, 1998,19: 30.
9Olszewska E, Chodynicki S, Chyczewski L. Apoptosis in the pathogenesis of choles'tea'toma in adults[J] . Eur Arch Otorhinolaryngol, 2006,263 : 409.
10Cory S, Huang DC, Adams JM. the Bcl-2 family: roles in ceil survival and oncogenesis [J] . Oncogene, 2003,22 : 6 590.
二级参考文献25
1[1]Parisier S C,Agresti C J,Schwartz G K,et al.Alteration in cholesteatoma fibroblasts:Induction of neoplastic-like phenotype.Am J Otol， 1993，14:126-130.
2[2]Desloge R B,Carew J F,Finstad J F，et al.DNA analysis of human cholesteatomas. Am J Otol，1997，18:155-159.
3[1]Chole RA. Ostahenko in chronic otitis media, Cholesteatoma and otosclerosis. Ann Otol Rhinol Laryngol,1988;97:661～666
4[2]Marrigama H, Honda Y, Huang CC,et al. Bone resorption in cholesteatoma: Epithelia-Mesenchymal cell interaction and collagenase production. Laryngoscope,1987;97:854～859
5[3]Dewhirst FE, Stashenko PP, Mole JE, et al. Purification and partial sequence of human osteoclast activating factor: identity with iterleukin 1 beta. J Immuno, 1985;135:2562～2568
6[4]Abramson M,Huang CC.Localization of collagenase in middle ear otitis media.J Laryngol Otol,1974;88:139～148
7[5]Jeffrey M, Huang CC, Abramson M. Interleukin 1 causing bone destruciton in middle ear cholesteatoma. Otolaryngol Head Neck Surg,1987;98:854～859
8[6]Amar MS, Wishahi HF, Zakhary MM. Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol,1996;110:534～539
9[7]Bretau P, Sorenser C, Jorgensen M. Bone resorption in human cholesteatoma. Ann Otol Rhinol Laryngol, 1982;91:131～135
10[8]Harris ED, Krane SM. Collagenases. New England Journal of Medicine, 1974;291:605～609
6Swartz J D.Currenrrt imaging approach to the temporal bone[J].Radiology,1989,171(2):309-315.
7Tamiya T,Kashiwagi I,Takahashi R,et al.Suppressors of cytokine signaling(SOCS)proteins and JAK/STAT pathways:regulation of T-cell inflammation by SOCS1 and SOCS3[J].Arterioscler Thromb Vasc Biol,2011,31:980.
8Martha LS,Abbie L,Lisa MH,et al.Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs:The breast cancer health disparities study[J].Breast Cancer Res Treat,2014,147:145.
9Park HR,Min SK,Min K,et al.Increased expression of p63and survivin in cholesteatomas[J].Acta Otolaryngol,2009,129:268.
10Teramo A,Gattazzo C,Passeri F,et al.Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia[J].Blood,2013,121:3843.
